BeStock  
Stocks › ELVN

Enliven Therapeutics ELVN

US equityMarket cap rank #2407
$45.47 −$1.50 (-3.19%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $45.20 -0.59%
Open$46.94
Prev close$46.97
Day range$45.23 – $46.94
Volume821.5K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership112.1%+0.32 pts vs. prior quarter
Institutions holding250+4 vs. prior quarter
Insider trades (recent)15 buys / 35 sellsNet selling
Short interest11.77% of floatDays to cover 9.0 · as of 15 Sep 2026
Short-sale volume share15.5%5-day average of daily volume

Short-sale volume as % of daily volume

8%12%16%20%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.89M (7 inflow days, 13 outflow days).

The five largest holders on file together own 43.1% of shares outstanding.

Largest holders

  • FMR13.68%
  • OrbiMed Advisors LLC9.25%
  • Polar Capital Holdings Plc8.78%
  • BlackRock5.95%
  • Vestal Point Capital, LP5.46%
  • Commodore Capital LP4.47%
  • T. Rowe Price Group, Inc.4.37%
  • Vanguard Capital Management, LLC4.03%

By investor type

  • Mutual Fund60.48%
  • Hedge Fund32.86%
  • VC/PE Fund14.54%
  • Individual/Insider2.69%
  • Sovereign Wealth Fund1.89%
  • Public Company1.40%
  • Insurance Company0.40%
  • Government Pension Fund0.29%

Reported short interest has fallen from 11.94% to 11.77% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 8,620,503 11.8% 9.0
31 Aug 2026 8,600,289 11.7% 11.1
14 Aug 2026 8,258,991 11.3% 6.3
31 Jul 2026 8,151,554 11.4% 11.4
15 Jul 2026 8,651,596 12.1% 9.4
30 Jun 2026 8,527,025 11.9% 3.1

Discussion

No comments yet — be the first to weigh in on ELVN.

Leave a comment

Scroll to Top